Rare diseases
Investigational molecules
Locations
Back to Spain56 clinical trials in Logrono, Spain. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SpainEnsayosClinicos.es(opens in a new tab)A study to evaluate the safety and effectiveness of HLX43 in patients with advanced non-small cell lung cancer
SpainPhase 1/2 Study of ter-2013-01, imlunestrant, and fulvestrant in patients with solid tumors with AKT/PI3K/PTEN pathway alterations
SpainSafety and Tolerability of Alisertib Sodium and Paclitaxel in Patients with Small Cell Lung Cancer (Phase 2 Study)
SpainPhase 1/2 First‑in‑Human Study of Oral GSK5471713B in Adults with Metastatic Castration‑Resistant Prostate Cancer
SpainEfficacy and Safety of Depemokimab for Early Intervention in Adults and Adolescents with Type 2 Asthma at Risk of Exacerbations
SpainStudy of RMC-6291 with ivonescimab drug combination in patients with advanced RAS‑mutated solid tumors
SpainPhase 1/2 Study of VS-7375 with Drug Combination in Patients with Advanced KRAS G12D‑Mutated Solid Tumors
SpainStudy of MK-6070 drug combination in first-line extensive-stage small cell lung cancer patients
SpainPhase 1/2 Study of CR-001 Safety and Dose Finding in Adults with Locally Advanced or Metastatic Solid Tumors
SpainEIK1005 Alone and with Pembrolizumab for Advanced Solid Tumors in Patients with MSI-H or dMMR Tumors
SpainZanidatamab, tucatinib, capecitabine or eribulin mesylate in HER2-positive advanced breast cancer in adults
SpainPhase 1/2A Study of OTP-01 to Evaluate Safety and Anti‑Tumor Activity in Patients with Advanced Solid Tumors
SpainThe busiest research cities in the country
What the registry says about research in the country
Innovative studies focusing on non-muscle invasive bladder cancer treatment, comparing electric current-administered mitomycin C with standard immunotherapy. Research includes evaluation of novel biomarkers for tumor detection.
Advanced therapeutic approaches combining traditional and innovative treatment methods.
Clinical research examining treatment outcomes for severe acute alcoholic hepatitis, investigating the effectiveness of combination therapy using methylprednisolone and N-acetylcysteine.
Focus on improving survival rates in severe cases.
Comprehensive studies on bacterial infections, including Pseudomonas aeruginosa bacteremia and Enterobacteriales infections. Evaluation of optimal antibiotic treatment durations and alternative therapeutic approaches.
Advancing antimicrobial stewardship through evidence-based research.
Breakthrough studies in multiple sclerosis treatment, comparing the efficacy of remibrutinib versus teriflunomide in managing relapsing forms of the disease.
Focused on improving quality of life for MS patients.
Investigation of treatment strategies for acute myocardial infarction, evaluating evolocumab's effectiveness in reducing cardiovascular events and hospitalizations.
Emphasis on real-world clinical outcomes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
